-Summary of the existing treatments with their evidence.-Presentation of the new topical treatments: -Ivermectin 1% cream: in the article it mentions phase III but it is actually already available in the United States. -Brominidine: it acts as an alpha-2 adrenergic vasoconstrictor and is already available on the market in Switzerland-Discussion of the other therapies